JAK2V617F mutation in patients with portal vein thrombosis.

JAK2V617F mutation in patients with portal vein thrombosis.

Item
http://www.wikidata.org/entity/Q46699180
JAK2 (V617F) Positive Latent Myeloproliferative Neoplasm Presenting with Splanchnic Vein ThrombosisJAK2V617F mutation in patients with thrombosis: to screen or not to screen?Childhood outcomes of neonates diagnosed with portal vein thrombosis.Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management.Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.Concurrent JAK2(V617F) mutation and MTHFR(C677T) homozygosity in an adolescent with polycythemia vera: case report and discussion.JAK2 (V617F) mutation is not associated with thrombosis in Behcet syndrome.Detection of mutations in JAK2 exons 12-15 by Sanger sequencing.Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?JAK2V617F mutation is ubiquitously present in splanchnic vein thrombosis accompanying myeloproliferative syndromes.Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis.
P2860

JAK2V617F mutation in patients with portal vein thrombosis.

Item
http://www.wikidata.org/entity/Q46699180
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
JAK2V617F mutation in patients with portal vein thrombosis.
@en
JAK2V617F mutation in patients with portal vein thrombosis.
@nl
type
label
JAK2V617F mutation in patients with portal vein thrombosis.
@en
JAK2V617F mutation in patients with portal vein thrombosis.
@nl
prefLabel
JAK2V617F mutation in patients with portal vein thrombosis.
@en
JAK2V617F mutation in patients with portal vein thrombosis.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
JAK2V617F mutation in patients with portal vein thrombosis.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921